Physiopathological mechanisms and morphological parameters involved in the progression of cutaneous melanoma
References
- Amin MB, Greene FL, Edge SB, et al. editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 546–64.
- Patterson JW. Weedon’s skin pathology. 5th ed. Amsterdam: Elsevier; 2020. p. 914–45.
- Calonje JE, Brenn T, Lazar AJ, et al. McKee’s pathology of the skin. 5th ed. Amsterdam: Elsevier; 2019. p. 1781–833.
- Bobos M. Histopathologic classification and prognostic factors of melanoma: a 2021 update. Ital J Dermatol Venereol. 2021;156(3):300–21. doi:10.23736/S2784-8671.21.06958-3.
- Ferlay J, Ervik M, Lam F, et al. Melanoma of the skin. In: Global Cancer Observatory: Cancer Today [Internet]. Lyon: International Agency for Research on Cancer; 2024 [cited 2026 Feb 16]. Available from: https://gco.iarc.who.int/today
- Fischer GM, Mahadevan NR, Hornick JL, et al. A comparative genomic study of conventional and undifferentiated melanoma. Mod Pathol. 2024;37(12):100626. doi:10.1016/j.modpat.2023.100626.
- Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics – update 2024. Eur J Cancer. 2025;215:115152. doi:10.1016/j. ejca.2024.115152.
- Puckett Y, Wilson AM, Farci F, et al. Melanoma pathology. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 Feb 16]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459225/
- Vița O, Jurescu A, Văduva A, et al. Invasive cutaneous melanoma: evaluating the prognostic significance of parameters associated with lymph node metastases. Medicina (Kaunas). 2023;59(7):1241. doi:10.3390/medicina59071241.
- Scolyer RA, Rawson RV, Gershenwald JE, et al. Melanoma pathology reporting and staging. Mod Pathol. 2020;33(Suppl 1):15–24. doi:10.1038/s41379-019-0371-x.
- Ernst M, Giubellino A. Current state of treatment and future directions in cutaneous malignant melanoma. Biomedicines. 2022;10(4):822. doi:10.3390/biomedicines10040822.
- Nethanel A, Kyprianou C, Barzilai A, et al. Implications of a dermatopathologist’s report on melanoma diagnosis and treatment. Life (Basel). 2023;13(9):1803. doi:10.3390/life13091803.
- Maher NG. Prognostic and predictive biomarkers in melanoma. Pathology. 2024;56(2):115–23. doi:10.1016/j.pathol.2023.12.003.
- Saginala K, Barsouk A, Aluru JS, et al. Epidemiology of melanoma. Med Sci (Basel). 2021;9(4):63. doi:10.3390/medsci9040063.
- Lopes J, Rodrigues CMP, Gaspar MM, et al. Melanoma management: from epidemiology to treatment and latest advances. Cancers (Basel). 2022;14(19):4652. doi:10.3390/cancers14194652.
- Federico S, Fortarezza F, Ingravallo G, et al. Epidemiology of skin cancer in 2024. In: Goldenberg G, editor. Skin cancer – past, present and future [Internet]. London: IntechOpen; 2025 [cited 2026 Feb 16]. doi:10.5772/ intechopen.1008035.
- American Cancer Society. Cancer facts and figures 2025 [Internet]. Atlanta (GA): American Cancer Society; 2025 [cited 2026 Feb 16]. Available from: https://www.cancer.org/
- Thompson JF, Williams GJ. Effect of age on melanoma incidence and prognosis. Aging (Albany NY). 2023;15(16):7857–9. doi:10.18632/ aging.204987.
- Roky AH, Islam MM, Ahasan AMF, et al. Overview of skin cancer types and prevalence rates across continents. Cancer Pathog Ther. 2025;3(2):89–100. doi:10.1016/j.cpt.2024.11.002.
- Caraviello C, Nazzaro G, Tavoletti G, et al. Melanoma skin cancer: a comprehensive review. Cancers (Basel). 2025;17(17):2920. doi:10.3390/cancers17172920.
- Crowson AN, Magro CM, Mihm MC Jr. Prognosticators of melanoma and sentinel lymph node. Mod Pathol. 2006;19(Suppl 2):S71–87. doi:10.1038/modpathol.3800519.
- Qasim H, Abu Shugaer M, Khattab K, et al. Histopathological subtypes of cutaneous melanoma: prognostic and molecular implications. Cureus. 2025;17(8):e90670. doi:10.7759/cureus.90670.
- Damsky WE, Rosenbaum LE, Bosenberg M. Decoding melanoma metastasis. Cancers (Basel). 2011;3(1):126–63. doi:10.3390/ cancers3010126.
- Gronbeck C, Kerr PE. Nodular melanoma. Clin Dermatol. 2025;43(1):64–70. doi:10.1016/j.clindermatol.2024.08.005.
- Hernandez LE, Frech FS, Mohsin N, et al. Nodular melanoma: pathogenesis, presentation, diagnosis, and treatment. J Dermatol Skin Sci. 2021;3(3):25–30.
- Allais BS, Beatson M, Wang H, et al. Five-year survival in nodular and superficial spreading melanoma. J Am Acad Dermatol. 2021;84(4):1015–22. doi:10.1016/j.jaad.2020.06.035.
- Xu C, Yu X, Ding Z, et al. AI-assisted metastasis and prognosis model in nodular melanoma. PLoS One. 2024;19(8):e0305468. doi:10.1371/ journal.pone.0305468.
- Liu Q, Peng Z, Shen L, et al. Prognostic value of Ki-67 in melanoma: a meta-analysis. Front Oncol. 2021;11:737760. doi:10.3389/fonc.2021.737760.
- Tapoi DA, Gheorghișan-Gălățeanu AA, Gosman LM, et al. Prognostic value of proliferative activity in cutaneous melanoma. Biomedicines. 2024;12(6):1318. doi:10.3390/biomedicines12061318.
- Gershenwald JE. Mitotic rate in primary cutaneous melanoma. Cancer. 2023;129(15):2290–3. doi:10.1002/cncr.34812.
- Namikawa K, Aung PP, Gershenwald JE, et al. Clinical impact of ulceration width and microsatellitosis in melanoma. Cancer Med. 2018;7(3):583–93. doi:10.1002/cam4.1332.
- Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307–17. doi:10.1056/NEJMoa060992.
- Cirocchi R, Metaj G, Cicoletti M, et al. Lymphatic drainage patterns during sentinel lymph node biopsy. J Clin Med. 2021;10(23):5544. doi:10.3390/jcm10235544.
- Venturi F, Magnaterra E, Scotti B, et al. Predictive factors for sentinel lymph node positivity in melanoma. Cancers (Basel). 2025;17(8):1281. doi:10.3390/cancers17081281.
Language: English
Page range: 119 - 125
Submitted on: Mar 15, 2026
Accepted on: May 22, 2026
Published on: Jul 3, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Mara Mironiuc, Andreea Cătălina Tinca, Ovidiu Simion Cotoi, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.